Your session is about to expire
← Back to Search
Behavioural Intervention
PROWESS Supportive Care for Prostate Cancer
N/A
Waitlist Available
Led By Daniel Lage, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline and weeks 12-14
Awards & highlights
Study Summary
This trial seeks to improve quality of life for Black & Hispanic/Latino prostate cancer patients through exercise, reduced side effects of ADT & health behavior change tools.
Who is the study for?
The PROWESS trial is for Black and Hispanic/Latino men over 18 with prostate cancer, who've been on ADT for at least three months. Participants should exercise less than 150 minutes per week, have access to a smartphone or computer with Bluetooth, and be fluent in English or Spanish. Those with significant health issues preventing informed consent, current chemotherapy treatment, short prognosis, or unable to do physical activity are excluded.Check my eligibility
What is being tested?
PROWESS is a behavioral change intervention aimed at increasing exercise among participants to reduce side effects from ADT and improve their quality of life. It involves using wearable technology and structured support tools integrated into the participant's healthcare routine.See study design
What are the potential side effects?
Since PROWESS focuses on behavior change rather than medication, typical drug-related side effects aren't expected. However, increased physical activity could lead to muscle soreness or strain especially if participants are not accustomed to regular exercise.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at baseline and weeks 12-14
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline and weeks 12-14
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Participant Satisfaction
Secondary outcome measures
Change in Objective Physical Activity
Change in Participant Distress
Change in Participant Quality of Life
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: PROWESSExperimental Treatment1 Intervention
Participants will complete study procedures as outlined:
Wear FitBit watch during the 12-week study period.
Group intervention sessions, in-person or virtually.
Two, optional follow-up sessions.
One-on-one, semi-structured interview with trained study staff to assess participant experience with intervention.
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,936 Previous Clinical Trials
13,198,713 Total Patients Enrolled
34 Trials studying Prostate Cancer
2,968 Patients Enrolled for Prostate Cancer
Daniel Lage, MDPrincipal InvestigatorMassachusetts General Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You need to have a smartphone or a computer with a USB Bluetooth adapter to participate.You identify as Black or Hispanic/Latino.You are able to speak English or Spanish fluently.Your primary oncologist thinks that you have less than 6 months to live.
Research Study Groups:
This trial has the following groups:- Group 1: PROWESS
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still opportunities to take part in this investigation?
"Unfortunately, according to clinicaltrials.gov, this medical investigation is no longer actively searching for patients - despite originally being posted on March 1st 2023 and updated last on February 22nd 2023. Despite this setback there are still 1305 other trials that require volunteers at present."
Answered by AI
Share this study with friends
Copy Link
Messenger